References
- Loubatières A, Mariani M M, Chapal J. Étude de la synergie entre le glucose et le tolbutamide dans les limites physio‐pathologiques de la glycémie. Compt Rend Acad Sci 1969; 269: 1460–63, Ser D
- Widström A, Cerasi E. On the action of tolbutamide in normal man. II. Modulation of glucose‐induced insulin release by tolbutamide. Acta Endocrinol 1973; 72: 519–31
- Pfeiffer M A, Halter J B, Beard J C, Porte D. Differential effects of tolbutamide on first and second phase insulin secretion in noninsulin‐dependent diabetes mellitus. J Clin Endocrinol Metab 1981; 53: 1256–62
- Grill V, Cerasi E. Interacting effects of sulfonylureas and glucose on cyclic AMP metabolism and insulin release in pancreatic islets of the rat. J Clin Invest 1978; 61: 1346–54
- Floyd J C, Fajans S S, Knopf R F, Conn J W. Evidence that insulin release is the mechanism for experimentally induced leucine hypoglycemia in man. J Clin Invest 1963; 42: 1714–9
- Grill V, Rundfeldt M. Effects of priming with D‐glucose on insulin secretion from rat pancreatic islets: increased responsiveness to other secreta‐gogues. Endocrinology 1979; 105: 980–7
- Cerasi E. Potentiation of insulin release by glucose in man. II. Role of the insulin response and enhancement of stimuli other than glucose. Acta Endocrinol 1975; 79: 502–10
- Efendic S, Wajngot A, Cerasi E, Luft R. Insulin release, insulin sensitivity and glucose intolerance. Proc Natn Acad Sci USA 1980; 77: 7425–9
- Ikkos D, Luft R. On the intravenous glucose tolerance test. Acta Endocrinol (Kbh) 1957; 25: 312–34
- WHO Expert Committee on Diabetes Mellitus. Technical report. Series 646, WHO, Geneva 1980
- Hugget A S, Nixon D A. Use of glucose oxidase peroxidase and o‐dianisidine in determination of blood and urinary glucose. Lancet 1957; 2: 368–70
- Herbert V, Lau K S, Gottlieb C W, Bleicher S J. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 1965; 25: 1375–84
- Faloona G R, Unger R H. Glucagon Radioimmunoassay technique. Methods of Hormone Radioimmunoassay, B M Jaffe, H E Behrman. Academic Press, New York 1974; 1: 324–6
- Grill V. Nutrient‐induced priming of insulin and glucagon secretion. Effect of α‐ketoisocaproic acid. Endocrinology 1982; 110: 1013–17
- Cataland S, Crockett S E, Brown J C, Mazzaferri E L. Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man. J Clin Endocrinol Metab 1974; 39: 223–8
- Ebert R, Arnold R, Creutzfeldt W. Lowering of fasting and food stimulated serum immunoreactive gastric inhibitory polypeptide (GIP) by glucagon. Gut 1977; 18: 121–30
- Dupré J, Ross S A, Watson D, Brown J C. Stimulation of insulin secretion by gastric inhibitory polypeptide in man. J Clin Endocrinol Metab 1973; 37: 826–8
- Floyd J C, Fajans S S, Conn J W, Knopff R F, Rull J. Insulin secretion in response to protein ingestion. J Clin Invest 1966; 45: 1479–86
- Sartor G, Melander A, Scherstén B, Wåhlin‐Boll E. Serum glibenclamide in diabetic patients and influence of food on the kinetics and effects of glibenclamide. Diabetologia 1980; 18: 17–22
- Sartor G, Lundqvist I, Melander A, Scherstén B, Wåhlin‐Boll E. Improved effect of glibenclamide on administration before breakfast. Eur J Clin Pharmacol 1982; 21: 403–8
- Hunt J N, Knox M T. Regulation of gastric emptying. Handbook of Physiology. Section 6. Alimentary Canal, C F Code. American Physiological Society, Washington, DC 1968; 4: 1917–35